Evidence map›Paper›PMID 40505451›Full record

ArticleInternational journal of surgery case reports2025

Pleomorphic carcinoma of the breast: A case report and review of the literature.

Nobuyuki Takemoto, Masanori Yasuda, Kousuke Shimanaka, Hiroshi Yamamoto

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nobuyuki TakemotoDepartment of Breast & Thyroid Surgery, Japan Medical Alliance East Saitama General Hospital, 5-517, Yoshino, Satte-City, Saitama-Pref, Japan. Electronic address: monochrome-rainbow@iijmio.mail.jp.
Masanori YasudaDepartment of Pathology, Japanese Red Cross Gifu Hospital, 36-3, Iwakuramachi, Gifu-City, Gifu-Pref, Japan.
Kousuke ShimanakaDepartment of Breast & Thyroid Surgery, Japan Medical Alliance East Saitama General Hospital, 5-517, Yoshino, Satte-City, Saitama-Pref, Japan.
Hiroshi YamamotoDepartment of Breast & Thyroid Surgery, Japan Medical Alliance East Saitama General Hospital, 5-517, Yoshino, Satte-City, Saitama-Pref, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and importancePleomorphic carcinoma of the breast is extremely rare, accounting for <0.1 % of breast malignancies. It has a poor prognosis, but its clinicopathologic features are not well characterized. CASE PRESENTATION: A 49-year-old woman was diagnosed with bilateral breast cancer (rt: cT2cN0M0 cstageIIA, lt: cT2cN1M0 cstageIIB) and its intrinsic type was non-luminal type (right breast) and lumina A-like (left breast). After neoadjuvant chemotherapy, the patient achieved pathologic partial response and underwent breast-conserving surgery with axillary lymph node dissection and radiotherapy. After 6 years and 7 months, local recurrence in the right breast was observed, and mastectomy was performed. However, after 4 weeks, metastasis to the contralateral breast was found, and a further 13 weeks later, 70 % of the thoracic cavity was occupied by metastatic pleural tumors. Pathological findings suggested pleomorphic carcinoma. The patient passed away 25 weeks later after the diagnosis of local recurrence. CLINICAL DISCUSSION: Pleomorphic carcinoma could represent an extreme end of dedifferentiation of invasive breast carcinoma of no special type or part of the differentiation of metaplastic spindle cell carcinoma. It is also important to differentiate this from malignant tumors such as sarcomas with giant cells or spindle cells, and metastatic tumors. Pathological diagnosis requires lack of heterologous non-epithelial components, and strong immunostaining with epithelial markers.

conclusionWhen a rapidly growing breast mass is encountered, pleomorphic carcinoma should be considered as one of diagnostic candidate. More case accumulation and analyses are awaited to further characterize this carcinoma.

Indexed as

BreastDifferential diagnosisPleomorphic carcinomaRapidly growing

Identifiers

PMID40505451
PMCPMC12192334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.